As the stock market goes crazy, here’s a FTSE 250 share I’m thinking about buying
The stock market has been all over the place today (23 March). First thing, the FTSE 100 nosedived and entered correction territory, meaning its tumble from a recent peak was 10%+. But as I type, the index has bounced back strongly.
The reason for this chaos, of course, is the highly unpredictable President Trump, who has threatened to destroy Iran’s energy infrastructure while also trying to reassure everyone the conflict will soon be over.
With the outcome uncertain and the Strait of Hormuz still effectively blocked, more investors now expect high inflation, interest rate hikes, and perhaps even a recession. So the risks are multiplying and the market has been reflecting this.
Now, I invested all the way through Trump’s first term in office, between 2017 and 2021. And that period also encompassed the outbreak of the pandemic, which likewise caused huge fear and uncertainty.
Yet the fact remains that the FTSE 100 is higher now — even after the recent pullback — than it was five years ago. And even if the conflict tips the global economy into recession, I fully expect the Footsie to move higher in future when markets settle down.
London could benefit
Indeed, the erratic policymaking by Trump could even benefit the London Stock Exchange. That’s the view of analysts at Berenberg, whose survey of over 400 global investors found more than a third planned to increase their exposure to UK stocks in the next year.
On the whole, UK stocks are cheaper than those across the pond. Many pay a decent dividend and are defensive in nature, while not exposed to potential AI disruption.
Mid-cap growth stock
One FTSE 250 share I’ve got my eye on is leading sports nutrition and supplements maker Applied Nutrition (LSE:APN). In its interim results (released today) for the six months to 31 January, it reported excellent progress.
Revenue surged 55.6% to £74.5m, while adjusted pre-tax profit was up 53.7% to £20.9m. And management left its annual revenue outlook unchanged, for about £140m, representing 30% year-on-year growth.
However, the situation in the Middle East is impacting shipping routes and its ability to serve customers there. As a result, management expects “some reduction in volumes into the region during the second half“.
The risk here then is that the Iran situation worsens, disrupting shipping routes and purchasing activities in the Middle East. This could hurt sales growth.
But taking a longer-term view, I like what I see here. The massive global sports nutrition, health, and wellness market is being boosted by tens of millions of people losing weight through GLP-1 drugs.
A high-protein diet is being recommended to GLP-1 users by doctors. So it’s encouraging to see that Applied Nutrition has launched a range of high-protein food with Morrisons. Early sales have been strong.
According to a recent McKinsey study, 84% and 79% of consumers respectively in the US and UK now see wellness as a top or important priority. Indeed, it’s their second-highest personal priority behind family.
Crucially, most now view supplements as a necessity rather than a luxury. So I think the company could continue growing even during an economic downturn. Its products cater for elite athletes, dedicated gym-goers, and everyday health-conscious consumers.
The stock is trading reasonably, at around 17 times forward earnings. I’m tempted.
The post As the stock market goes crazy, here’s a FTSE 250 share I’m thinking about buying appeared first on The Motley Fool UK.
Should you invest £1,000 in Applied Nutrition Plc right now?
When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.
And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Applied Nutrition Plc made the list?
More reading
- As the FTSE 100 falls, savvy investors are looking for stocks to buy for the rebound
- 2 UK stocks to consider buying as Mounjaro and Wegovy take off
- 2 top growth stocks to consider for an ISA in April
- Up 79% in a year, this FTSE 250 stock still gets a resounding Strong Buy from analysts
- £1,000 buys 398 shares in this red hot UK stock thatâs smashing Raspberry Pi
Ben McPoland has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
